Association of risk of non-Hodgkin’s lymphoma with hepatitis B virus infection: A meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 12, 2015, Pages 22167-22174

  Qi, Zhenjia ^a   Wang, Hao ^b   Gao, Guangxun ^c  

^a No 4 Centyal Hospital of Tianjin   (China)

^b Xi'an Child's Hospital   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Meta analysis; Non Hodgkin s lymphoma; Risk

Indexed keywords

CANCER GROWTH FACTOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RISK; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; META ANALYSIS; NONHODGKIN LYMPHOMA; PROTEIN EXPRESSION;

EID: 84957111146     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Rapti I, Hadziyannis S. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues. World J Hepatol 2015; 7: 1064-73.
2. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW; Centers for Disease Control and Prevention (CDC). Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008; 57: 1-20.
3. Persico E, De Renzo A, La Mura V, Bruno S, Masarone M, Torella R, Persico M. Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: The need for early diagnosis in anti-Hbv positive patients. Gut 2007; 56: 1470-1471.
4. Yang G, Han M, Chen F, Xu Y, Chen E, Wang X, Liu Y, Sun J, Hou J, Ning Q, Wang Z. Hepatitis B virus genotype B and mutations in basal core promoter and pre-core/core genes associated with acute-on-chronic liver failure: a multicenter cross-sectional study in China. Hepatol Int 2014; 8: 508-516.
5. Martin P, Lau DT, Nguyen MH, Janssen HL, Dieterich DT, Peters MG, Jacobson IM. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update. Clin Gastroenterol Hepatol 2015; 13: 2071-2087.e16.
6. Laurent C, Do C, Gourraud PA, de Paiva GR, Valmary S, Brousset P. Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases. Medicine (Baltimore) 2015; 94: e987.
7. Cucuianu A, Patiu M, Duma M, Basarab C, Soritau O, Bojan A, Vasilache A, Mates M, Petrov L. Hepatitis B and C virus infection in Romanian non-Hodgkin’s lymphoma patients. Br J Haematol 1999; 107: 353-356.
8. Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, Fukutomi M, Yokota M, Nishi H, Iwamoto H, Uike N, Nishimura J, Inaba S, Maeda Y, Nawata H, Muta K. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin’s lymphoma. J Gastroenterol Hepatol 2001; 16: 215-219.
9. Kim JH, Bang YJ, Park BJ, Yoo T, Kim CW, Kim TY, Heo DS, Lee HS, Kim NK. Hepatitis B virus infection and B-cell non-Hodgking lymphoma in a hepatitis B endemic area: A case-control study. Jpn J Cancer Res 2002; 93: 471-477.
10. Lwata H, Matsuo K, Takeuchi K, Kishi Y, Murashige N, Kami M. High incidences of malignant lymphoma in patients infected with hepatitis B or hepatitis C virus. Haematologica 2004; 89: 369-370.
11. E1-Sayed GM, Mohamed WS, Nouh MA, Moneer MM, El-Mahallawy HA. Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of egyptian non-Hodgkin’s lymphoma patients. Egypt J Immunol 2006; 13: 105-114.
12. Marcucci F, Mele A, Spada E, Candido A, Bianco E, Pulsoni A, Chionne P, Madonna E, Cotichini R, Barbui A, De Renzo A, Dore F, Iannitto E, Liso V, Martino B, Montanaro M, Pagano L, Musto P, Rapicetta M. High prevalence of hepatitis B virus infection in B-cell non-Hodgking lymphoma. Haematologica 2006; 91: 554-557.
13. Mehdi SR, A1Ajlan AR. Hepatitis B & C virus infection in cases of non-Hodgkin’s lymphomain Saudi Arabia. Turk J Hematol 2006; 23: 200-204.
14. Lim ST, Fei G, Quek R, Lim LC, Lee LH, Yap SP, Loong S, Tao M. The relationship of hepatitis B virus infection and non-Hodgkin’s lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007; 79: 132-137.
15. Sonmez M, Bektas O, Yilmaz M, Durmus A, Akdogan E, Topbas M, Erturk M, Ovali E, Omay SB. The relation of lymphoma and hepatitis B virus/hepatitis C virus infections in the region of east black sea, Turkey. Tumori 2007; 93: 536-539.
16. Wang F, Xu RH, Hart B, Shi YX, Luo HY, Jiang WQ, Lin TY, Huang HQ, Xia ZJ, Guan ZZ. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 2007; 109: 1360-1364.
17. Park SC, Jeong SH, Kim J, Kim YC, Choi KS, Cho JH, Lee M, Jung HH, Ki SS, Chang YH, Lee SS, Park YH, Lee KH. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin’s lymphoma in Korea. J Med Virol 2008; 80: 960-966.
18. Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA. Hematopoietie malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 2008; 17: 3069-3075.
19. Cocco P, Piras G, Monne M, Uras A, Gabbas A, Ennas MG, Palmas A, Murineddu M, Collu S, Melis M, Rais M, Todde P, Cabras MG, Angelucci E, Massarelli G, Nieters A. Risk of malignant lymphoma following viral hepatitis infection. Int J Hematol 2008; 87: 474-483.
20. Becker N, Fortuny J, Alvaro T, Nieters A, Maynadié M, Foretova L, Staines A, Brennan P, Boffetta P, Cocco PL, de Sanjose S. Medical history and risk of lymphoma: Results of a European case-control study (EPILYMPH). J Cancer Res Clin Oncol 2009; 135: 1099-1107.
21. Franceschi S, Lise M, Trepo C, Berthillon P, Chuang SC, Nieters A, Travis RC, Vermeulen R, Overvad K, Tjønneland A, Olsen A, Bergmann MM, Boeing H, Kaaks R, Becker N, Trichopoulou A, Lagiou P, Bamia C, Palli D, Sieri S, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita B, Peeters PH, Rodríguez L, Barroso LL, Dorronsoro M, Sánchez MJ, Navarro C, Barricarte A, Regnér S, Borgquist S, Melin B, Hallmans G, Khaw KT, Wareham N, Rinaldi S, Hainaut P, Riboli E, Vineis P. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European prospective investigation into cancer and nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2011; 20: 208-214.
22. Kang J, Cho JH, Suh CW, Lee DH, Oh HB, Sohn YH, Chi HS, Park CJ, Jang SS, Lee KH, Lee JH, Lee JH, Lee SW, Chung YH, Kim TH, Shin HR, Huh J. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol 2011; 90: 159-164.
23. Kim YM, Jeong SH, Kim JW, Lee SH, Hwang JH, Park YS, Kim N, Lee JS, Kim HY, Lee DH. Chronic hepatitis B, non-Hodgkin’s lymphoma, and effect of prophylactic antiviral therapy. J Clin Virol 2011; 51: 241-245.
24. Luo LH, Fan Y, Huang ZY. Correlation between HBV infection and NHL. Zhong Hua Zhong Liu Fang Zhi Za Zhi 2010; 17: 1414-1417.
25. Yan XT, Zhang MZ, Chang Y. Analysis of the relationship between NHL and HBV infection. Yi Yao Lun Tai Za Zhi 2009; 30: 24-25.
26. Zhang SL, Chen DP, Wang BQ. Analysis of the relationship between NHL and HBV infection. Xian Dai Zhong Liu Yi Xue 2010; 18: 1005-1006.
27. Ma AF. Relationship between HBV infection in patients with NHL and Prognosis. Lin Chuang Yi Yao Shi Jian 2011; 20: 173-175.
28. Qin XT, Lv Y, Chen XQ, Xu HP, Fan HJ. Relationship between HBV infection and NHL. Ai Zheng 2007; 26: 294-297.
29. Luo CL, Zhao XH. Clinical analysis of NHL with hepatitis B virus infection. Zhong Guo Shi Yong Yi Yao 2011; 6: 108-109.
30. Becker N, Schnitzler P, Boffetta P, Brennan P, Foretova L, Maynadié M, Nieters A, Staines A, Benavente Y, Cocco P, de Sanjose S. Hepatitis B virus infection and risk of lymphoma: Results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol 2012; 138: 1993-2001.
31. Lu L, Zhang HY, Yueng YH, Cheung KF, Luk JM, Wang FS, Lau GK. Intracellular levels of hepatitis B virus DNA and pregenomie RNA in peripheral blood mononuclear cells of chronically infected patients. J Viral Hepat 2009; 16: 104-112.
32. Wang L, Wang H, Wang JH, Xia ZJ, Lu Y, Huang HQ, Jiang WQ, Zhang YJ. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase. Oncotarget 2015; 6: 30317-26.
33. Maeshima AM, Taniguchi H, Nomoto J, Makita S, Kitahara H, Fukuhara S, Munakata W, Suzuki T, Maruyama D, Kobayashi Y, Tobinai K. Clinicopathological features of classical Hodgkin lymphoma in patients ≥40 years old, with special reference to composite cases. Jpn J Clin Oncol 2015; 45: 921-8.
34. Lu TX, Liang JH, Miao Y, Fan L, Wang L, Qu XY, Cao L, Gong QX, Wang Z, Zhang ZH, Xu W, Li JY. Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age. Sci Rep 2015; 5: 12168.
35. McAulay KA, Jarrett RF. Human leukocyte antigens and genetic susceptibility to lymphoma. Tissue Antigens 2015; 86: 98-113.